Tags

Type your tag names separated by a space and hit enter

[Clinical pharmacology and therapeutic aspects in certain degenerative neurological diseases].
Bull Mem Acad R Med Belg. 1996; 151(10-11):429-32; discussion 432-4.BM

Abstract

The knowledge in the pathophysiology of neurodegenerative disorders, and their classification has been dramatically improved by the progresses in genetics and molecular biology. Such a progress has not yet been observed in therapeutics but sustained symptomatic results may occur in the treatment of Parkinson's disease and to a lesser extent in Alzheimer's disease. More recently, other therapeutic approaches were used in trials with neuroprotective drugs with some encouraging results.

Authors

No affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

9491620

Citation

Maloteaux, J M.. "[Clinical Pharmacology and Therapeutic Aspects in Certain Degenerative Neurological Diseases]." Bulletin Et Memoires De l'Academie Royale De Medecine De Belgique, vol. 151, no. 10-11, 1996, pp. 429-32; discussion 432-4.
Maloteaux JM. [Clinical pharmacology and therapeutic aspects in certain degenerative neurological diseases]. Bull Mem Acad R Med Belg. 1996;151(10-11):429-32; discussion 432-4.
Maloteaux, J. M. (1996). [Clinical pharmacology and therapeutic aspects in certain degenerative neurological diseases]. Bulletin Et Memoires De l'Academie Royale De Medecine De Belgique, 151(10-11), 429-32; discussion 432-4.
Maloteaux JM. [Clinical Pharmacology and Therapeutic Aspects in Certain Degenerative Neurological Diseases]. Bull Mem Acad R Med Belg. 1996;151(10-11):429-32; discussion 432-4. PubMed PMID: 9491620.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Clinical pharmacology and therapeutic aspects in certain degenerative neurological diseases]. A1 - Maloteaux,J M, PY - 1996/1/1/pubmed PY - 1998/3/10/medline PY - 1996/1/1/entrez SP - 429-32; discussion 432-4 JF - Bulletin et memoires de l'Academie royale de medecine de Belgique JO - Bull. Mem. Acad. R. Med. Belg. VL - 151 IS - 10-11 N2 - The knowledge in the pathophysiology of neurodegenerative disorders, and their classification has been dramatically improved by the progresses in genetics and molecular biology. Such a progress has not yet been observed in therapeutics but sustained symptomatic results may occur in the treatment of Parkinson's disease and to a lesser extent in Alzheimer's disease. More recently, other therapeutic approaches were used in trials with neuroprotective drugs with some encouraging results. SN - 0377-8231 UR - https://www.unboundmedicine.com/medline/citation/9491620/[Clinical_pharmacology_and_therapeutic_aspects_in_certain_degenerative_neurological_diseases]_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -